Chief Operating Officer at Verily Life Sciences
Ashraf Hanna is the chief operating officer of Verily. Previously he was the CEO of ORIC Pharmaceuticals, a company focused on the development of treatments for cancer resistance. Before that Ashraf spent nearly 11 years as a Vice President at Genentech leading the Commercial and Medical Affairs Finance functions, as well as Alliance Management and Portfolio Planning group, which is responsible for developing metrics and process for guiding R&D investments. Ashraf was also the CFO for the Genentech foundation, and previously at McKinsey and Company. He is a graduate of University of Chicago, has a Ph.D. in Physics from Harvard University and an M.D. from the University of Massachusetts.
Director, Data Analytics & Consulting of EIU Healthcare
Chee is an experienced consultant in the healthcare and life sciences sector in North America and Asia Pacific, with more than 20 years of experience in business and operational strategy consulting, leveraging strong market research capabilities. She has more than 12 years of healthcare experience specifically in China.
Prior to EIU Healthcare/Clearstate, Chee was the Strategy & Change Pharmaceutical leader in IBM Global Business Services (previously PricewaterhouseCoopers) in China. Before that, she was with the North American R&D pharmaceutical industry practice based in Toronto.
Chee has extensive experience working with senior executives of both healthcare and life sciences companies and government organizations to develop and implement strategic plans.
Chee focuses on medtech clients globally, working with global leaders such as Abbott Diagnostics, Boston Scientific, Medtronic, Roche Diagnostics, Danaher and Philips. Chee has managed large scale projects to provide credible market insights to help clients achieve sustainable growth. She has led numerous consulting projects to formulate winning go-to-market strategies in emerging markets in Asia Pacific and Latin America.
She has published various white papers and presented at major conferences on current healthcare topics in Asia. She has covered topics such as “Future Outlook for Health in China”, “SE Asia: The New Emerging Healthcare Market Challenge”, “Digital Healthcare”, etc.
Chee holds an MBA from Schulich School of Business, York University (Canada) and BSc (Hons) in Microbiology from University of Toronto
Director, Hong Kong of The Economist Corporate Network
Janet Pau is the Director of The Economist Corporate Network in Hong Kong. She brings her experience working with top executives throughout Asia, coupled with economic knowledge and industry insight to help organisational leaders and their teams gain a holistic, practical appreciation of the opportunities and challenges in Greater China and across Asia.
Before joining The Economist Corporate Network, Janet was Program Director for the Asia Business Council, developing and delivering content for private forums for an all-CEO membership in Asia for more than a decade. Prior to that, she was Manager at the Global Business Policy Council at consulting firm A.T. Kearney in Washington D.C., where she led consulting projects and intellectual capital publications for senior executive clients in both business and government.
Janet’s publications include Through the Eyes of Tiger Cubs: Views of Asia’s Next Generation (Wiley, 2012) and Building Energy Efficiency (Encyclopaedia of China Publishing House, Chinese edition, 2008). She was an op-ed contributor and columnist for the South China Morning Post from 2011 to 2019. She has also contributed opinion pieces and book chapters, and spoken at various local and regional business conferences.
She serves on the leadership team of Hong Kong-based charity Beyond Foundation, which advocates for children with special needs and their families. She was a member on the Hong Kong Government’s Antiquities Advisory Board, Museum Advisory Board, and Central Policy Unit.
Janet received a Bachelor of Arts degree in international studies and psychology with honours from Yale University and a Master in Public Policy specializing in economic policy and competitiveness from Harvard University.